<p>S&P Global Ratings credit analyst Arthur Wong discusses the ratings and outlook on Merck & Co. Inc., prospects of Keytruda, and what capacity the company has for acquisitions at the current ratings.</p>

S&P Global Ratings credit analyst Arthur Wong discusses the ratings and outlook on Merck & Co. Inc., prospects of Keytruda, and what capacity the company has for acquisitions at the current ratings.

<p>S&amp;P Global Ratings credit analyst Arthur Wong discusses the ratings and outlook on Merck &amp; Co. Inc., prospects of Keytruda, and what capacity the company has for acquisitions at the current ratings.</p>

Episode 13: Four Takeaways - Merck  Co.

Hosted by Arthur Wong, Ji Liu, and other editors and analysts, the S&P Pharma Dose podcast from S&P Global Ratings discusses all things pharma from a credit perspective.

Business

News

Business News

Hosted by Arthur Wong, Ji Liu, and other editors and analysts, the S&amp;P Pharma Dose podcast from S&amp;P Global Ratings discusses all things pharma from a credit perspective.

Share Episode 13: Four Takeaways - Merck Co.

Sign up to save your podcasts

Episode 13: Four Takeaways - Merck Co.

Episode 13: Four Takeaways - Merck Co.